The inflammatory bowel disease (IBD) treatment market was valued at USD 19.60 billion in 2024 and is expected to reach USD 34.15 billion by 2034, growing at a CAGR of 5.71%. Key drivers include the rising prevalence of IBD across major markets and advancements in therapeutic options for Crohn’s disease and ulcerative colitis. https://www.expertmarketresearch.com/reports/inflammatory-bowel-disease-treatment-market